254 related articles for article (PubMed ID: 19489066)
1. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers.
Schroeder AS; Ertl-Wagner B; Britsch S; Schröder JM; Nikolin S; Weis J; Müller-Felber W; Koerte I; Stehr M; Berweck S; Borggraefe I; Heinen F
Mov Disord; 2009 Jul; 24(10):1494-503. PubMed ID: 19489066
[TBL] [Abstract][Full Text] [Related]
2. Different types of botulinum toxin in humans.
Eleopra R; Tugnoli V; Quatrale R; Rossetto O; Montecucco C
Mov Disord; 2004 Mar; 19 Suppl 8():S53-9. PubMed ID: 15027055
[TBL] [Abstract][Full Text] [Related]
3. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.
Manske SL; Boyd SK; Zernicke RF
Bone; 2010 Jan; 46(1):24-31. PubMed ID: 19853070
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of botulinum toxin A in children with cerebral palsy.
Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
[TBL] [Abstract][Full Text] [Related]
5. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
Lange F; van Weerden TW; van der Hoeven JH
Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
[TBL] [Abstract][Full Text] [Related]
6. Increased electrotonic coupling in spinal motoneurons after transient botulinum neurotoxin paralysis in the neonatal rat.
Pastor AM; Mentis GZ; De La Cruz RR; Díaz E; Navarrete R
J Neurophysiol; 2003 Feb; 89(2):793-805. PubMed ID: 12574457
[TBL] [Abstract][Full Text] [Related]
7. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
8. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular distribution of botulinum toxin--visualized by MRI.
Elwischger K; Kasprian G; Weber M; Meyerspeer M; Linder C; Auff E; Prayer D; Sycha T; Kranz G
J Neurol Sci; 2014 Sep; 344(1-2):76-9. PubMed ID: 25023196
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of therapeutic botulinum toxin preparations.
Dressler D; Benecke R
Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
Esquenazi A; Mayer NH; Elia AE; Albanese A
Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
[TBL] [Abstract][Full Text] [Related]
14. NeuroBloc/Myobloc: unique features and findings.
Arezzo JC
Toxicon; 2009 Oct; 54(5):690-6. PubMed ID: 19286001
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.
Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R
Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: a study in rats.
Ma J; Shen J; Lee CA; Elsaidi GA; Smith TL; Walker FO; Rushing JT; Tan KH; Koman LA; Smith BP
J Orthop Res; 2005 Mar; 23(2):302-9. PubMed ID: 15734240
[TBL] [Abstract][Full Text] [Related]
19. Mechano- and metabosensitive alterations after injection of botulinum toxin into gastrocnemius muscle.
Caron G; Rouzi T; Grelot L; Magalon G; Marqueste T; Decherchi P
J Neurosci Res; 2014 Jul; 92(7):904-14. PubMed ID: 24615939
[TBL] [Abstract][Full Text] [Related]
20. Pain and calf hypertrophy associated with spontaneous repetitive discharges treated with botulinum toxin.
Costa J; Graça P; Evangelista T; de Carvalho M
Clin Neurophysiol; 2005 Dec; 116(12):2847-52. PubMed ID: 16256429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
